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The Chinese herb modiﬁed Yi Guan Jian (mYGJ) is an eﬀective regimen that is usually used in outpatients with chronic liver
diseasessuchasﬁbrosisandcirrhosis.However,themechanismfortheactionofmYGJonliverﬁbrosisisnotyetclear.Inthisstudy,
we found that mYGJ induced hepatic stellate cells (HSCs) apoptosis concomitant with the downregulation of Bcl-2 expression and
slightelevationofBaxlevel.Moreover,thereactiveoxygenspecies(ROS)weregeneratedintheearlystagesofmYGJ-inducedHSCs
apoptosis to facilitate calcium and cytochrome c release from the mitochondria to cytosol. Subsequently, caspase 9 and caspase
3 were activated. Furthermore, the activation of ER stress-associated caspase 12 in HSCs was also evaluated. Together, we report
the ﬁrst evidence-based study to demonstrate that mYGJ decoction induces HSCs apoptosis through ROS accumulation and the
intrinsic apoptosis pathway. These ﬁndings provide rationale for further clinical investigation of traditional Chinese medicine
recipes against liver ﬁbrosis.
1.Introduction
Liver ﬁbrosis is caused by severe liver damage that occurs in
many patients with liver injury such as persistent viral and
helminthic infections, overuse of alcohol or nonalcoholic
steatohepatitis (NASH), autoimmunity, drug intoxication,
and some hereditary disease [1, 2]. Hepatic stellate cell
(HSC) proliferation and activation are thought to be crucial
for the progression of liver ﬁbrosis [3]; HSCs change from
a quiescent status to activation and undergo transformation
into myoﬁbroblast-like cells which produce excessive extra-
cellular matrix (ECM) proteins including α-smooth muscle
actin (α-SMA) and type I collagen. Excessive depositions
of these ECM proteins in liver tissue result in ﬁbrogenesis
and disturb matrix degradation that causes the loss of
homeostasis in liver tissue followed by progression to liver
cirrhosis and hepatocellular carcinoma [4, 5].
Recent studies reveal that liver ﬁbrosis and cirrhosis is a
reversible process [6, 7]. Removal of the liver injury-causing
factors followed by a decrease in proinﬂammatory cytokines
and an induction of activated HSC apoptosis may cause
liver ﬁbrosis diminution [8]. Therefore, suppression of HSC
activation and proliferation and induction of apoptosis in
activated HSCs have been proposed as therapeutic strate-
gies for the treatment and prevention of hepatic ﬁbrosis
[1, 9, 10].
Yi Guan Jian (YGJ) decoction consists of six kinds
of Chinese herbs and is a traditional Chinese hepato-
therapeutic herbal formula. According to the Chinese
medicine theory, the modiﬁed Yi Guan Jian (mYGJ) is
formulated by adding three more herbs including Astra-
galus membranaceus, Trionyx sinensis Wiegmann (Carapax
Trionycis), and Eupolyphaga sinensis Walker into the original
YGJ to activate blood and resolve stasis, toniﬁes qi, and
hard mass for the patients with liver diseases. Although
there is still no evidence-based clinical study, YGJ has shown
apparent eﬃcacy in outpatients with chronic liver diseases
such as ﬁbrosis and cirrhosis to improve clinical symptoms,2 Evidence-Based Complementary and Alternative Medicine
liver function, and quality of life for patients. Besides,
the major active components of YGJ extract, ferulic acid
and catalpol, signiﬁcantly inhibit the progression of hepatic
ﬁbrosis in carbon tetrachloride-induced animal model study
[11].However,theunderlyingmechanismfortheantiﬁbrotic
eﬀects of YGJ or mYGJ is still unclear. In this study, we
demonstrate that mYGJ inhibits HSC-T6 hepatic stellate cell
proliferation concomitant with a signiﬁcant decrease in the
expression of liver ﬁbrosis marker α-SMA. This eﬀect is
mediated by induction of HSCs apoptosis through an ROS-
mediated mitochondrial/caspase signaling pathway. These
ﬁndings thereby show for the ﬁrst time the experimental
evidence for the antiﬁbrotic eﬀects of mYGJ.
2. Methods
2.1. Materials. The anti-α-SMA, anti-β-actin, and catalase
were purchased from Sigma (Saint Louis, MO). The anti-
Bcl-2, anti-Bax, and anti-GRP78 antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
The anticaspase 3, anticleaved caspase 9, and anticalpain
antibodies were purchased from Cell Signaling Technol-
ogy (Beverly, MA). The Mitochondria/Cytosol Fractiona-
tion Kit and the anticytochrome c antibody were pur-
chased from BioVision (Mountain View, CA). The Flu-
orescein FragEL DNA Fragmentation Detection Kit was
purchased from EMD Chemicals (Gibbstown, NJ). The 3-
(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) assay kit was pur-
chased from Promega (Madison, WI).
2.2. Preperation of Modiﬁed Yi Guan Jian. The mYGJ extract
was kindly provided by Ko-Da Pharmaceutical Company,
Taiwan. The composition of mYGJ was listed in Table 1
and the index constituents were shown in the Supplemental
Figure 1. The mYGJ liquid extracts were composed of
Glehnia littoralis F., Ophiopogon japonicus (L. f.) Ker-
Gawl., Angelica sinensis (Oliv.) Diels., Rehmannia gluti-
nosa Libosch., Lycium barbarum L., Melia toosendan Sieb.
et Zucc., Astragalus membranaceus (Fisch.) Bge., Trionyx
sinensis Wiegmann., and Eupolyphaga sinensis Walker. The
three components of modiﬁed YGJ that were diﬀerent from
original YGJ were listed in Table 1 with bold face. The
concentration for the ﬁnal stock solution of mYGJ extract
was 175mg/mL.
2.3. Cell Culture and Proliferation Assay. The immortalized
ratmyoﬁbroblastcelllineHSC-T6wasakindgiftofDr.Scott
L. Friedman (Mount Sinai School of Medicine, New York,
NY). The cells were cultured in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) supplemented with 10% fetal bovine
serum at 37◦C in a humidiﬁed atmosphere of 5% CO2.
For cell proliferation assay, the HSC-T6 cells were seeded
into a 96-well culture plate at a cell density of 1 × 104
cells/well for 24 hours. Then, the cells were treated with a
serial concentration of mYGJ for the indicated time and cell
proliferation was determined by MTS assay as described by
the manufacture (Promega).
2.4. Western Blot Analysis. The cell lysates were harvested
in lysis buﬀer (50mM HEPES, pH 7.5, 150mM NaCl,
1% Triton X-100, 1.5mM MgCl2, 10% glycerol, protease
inhibitor cocktail (Invitrogen)) and were separated on a
10% SDS-polyacrylamide gel as described previously [12].
For cellular fractionation of cytochrome c, the cytosolic
and the mitochondria fractions of the lysates were obtained
using the Mitochondria/Cytosol Fractionation Kit according
to the manufacturer’s (BioVision) instruction. Western blot
analysis was then performed as described in [13].
2.5. TUNEL Assay. Terminal deoxynucleotidyl transferase
(TdT) dUTP nick end labeling (TUNEL) was performed
by the Fluorescein FragEL DNA Fragmentation Detection
Kit according to the manufacturer’s (EMD Chemicals)
instruction. Brieﬂy, HSC-T6 cells (1 × 106 cells/35-mm
culture dish) were treated with the indicated dose of mYGJ.
At 72 hours after treatment, the cells were ﬁxed with 4%
paraformaldehyde at room temperature for 30 minutes. The
ﬁxedcellswerewashedwithphosphate-buﬀeredsaline(PBS)
and then cytospun to transfer cells to a glass slide. The
cells were then treated with proteinase K (2μg/mL) at room
temperature for 5 minutes. After adding 100μLo fT d T
equilibration buﬀer for 30 minutes, the cells were incubated
with 60μL of TdT Labeling Reaction Mix (containing 3μL
TdT) at 37◦C for 1 hour. Following several washes with Tris-
buﬀered saline (TBS), the stained cells were observed by
ﬂuorescence microscopy (OLYMPUS, IX70).
2.6. Measurements of Reactive Oxygen Species (ROS) and
Cytosolic Calcium Concentration. For measurements of ROS
accumulation and quantiﬁcation, the cells were incubated
with medium containing 1μMH 2DCFDA (Molecular
p r o b e s )i nd a r ka t3 7 ◦C for 30 minutes. The cells were
trypsinized, washed by PBS, and then analyzed immediately
by ﬂow cytometry using FACS Calibur (Becton Dickinson).
Forcatalasecompensationassay,thecatalase(600U/mL)was
added into culture media for 2 hours before incubation with
H2DCFDA.
For measurement of cytosolic calcium concentration, the
cells were treated with 1μM Fluo-4/AM (BIOCHEMIKA)
in dark at room temperature for 30 minutes. After washing
twicewith1XPBS,thecellsweresubjectedtoﬂowcytometric
analysis.
2.7. Statistical Analysis. Data were expressed as mean ±
standard deviation (SD) or mean ± standard error (SE).
Statistical analysis was performed by Student’s t-test. A P<
.05 was considered as statistically signiﬁcant.
3. Results
3.1. mYGJ Induces HSC-T6 Cell Apoptosis and Inhibits Liver
Fibrosis Marker Protein. In this study, we used HSC-T6
cells to evaluate whether the traditional Chinese medicine
decoction mYGJ elicits antiliver ﬁbrosis activity. At ﬁrst, the
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Figure 1:ThemYGJexhibitspotentantiﬁbrosisactivityonHSC-T6cells.(a)HSC-T6cellswereseededonto96-wellplatesandtheindicated
dose of mYGJ was added to the medium for 24, 48, and 72 hours, respectively. Cell viability was measured by MTS assay as described in the
Material and methods. The data represented the mean ± S.D. of three independent experiments. (b) HSC-T6 cells were treated with the
indicated concentration of mYGJ. The cell lysates were harvested at 48 and 72 hours posttreatment and were subjected to Western blot
analysis using the anti-α-SMA antibody. The expression of β-actin was used for the control of equal protein loading. The band intensity
of Bcl-2 or Bax versus β-actin was determined and the relative ratio to control experiment which did not treat with mYGJ was indicated
below the data. (c) Representative photographs of HSC-T6 cells that were treated with the indicated concentrations of mYGJ for 72 hours.
The determination of apoptosis was performed by TUNEL assay with the apoptotic cells appeared with green ﬂuorescence. Nuclei were
counter-stained using DAPI (blue).
Table 1: Composition of modiﬁed Yi Guan Jian.
Plant name Family Part used Composition
Glehnia littoralis F. Umbelliferae Radix 3 (9.8%)
Ophiopogon japonicus (L. f.) Ker- Gawl. Liliaceae Radix 3 (9.8%)
Angelica sinensis (Oliv.) Diels. Umbelliferae Radix 3 (9.8%)
Rehmannia glutinosa Libosch. Scrophulariaceae Radix Rhizoma 6 (19.7%)
Lycium barbarum L. Solanaceae Fructus 3 (9.8%)
Melia toosendan Sieb. et Zucc. Meliae Fructus 1.5 (5%)
Astragalusmembranaceus (Fisch.) Bge. Leguminosae Radix 3(9.8%)
Trionyxsinensiswiegmann. Trionychidae Shell 5(16.4%)
Eupolyphaga sinensiswalker. Corydiidae Dried body of female 3 (9.8%)
Total:30.5 (100%)
Provided by Ko-Da pharmaceutical co. Taiwan.4 Evidence-Based Complementary and Alternative Medicine
by MTS assay. The data indicated that mYGJ inhibited cell
survival in a dose-dependent manner (Figure 1(a)). The
concentration required for 50% inhibition of growth (IC50)
was about 300μg/mL after 72 hours treatment (n = 3).
Concomitant with the decrease in cell growth, expression
of the stellate cell activation marker protein α-SMA was
also inhibited by mYGJ (Figure 1(b)). These data indicate
that mYGJ inhibits HSC-T6 hepatic stellate cell proliferation
concomitantwithadecreaseintheexpressionofliverﬁbrosis
marker α-SMA.
To determine whether apoptosis is the underlying mech-
anism for mYGJ to suppress stellate cell growth, HSC-T6
cells were treated with various concentrations of mYGJ for
72 hours and were subjected to TUNEL staining using
ﬂuorecein-labeled dUTP for assessment of the degree of
apoptosis. As shown in Figure 1(c), the number of TUNEL-
positive cells was increased proportional to the increase in
the dosage of mYGJ. The apoptotic index as deﬁned by
the percentage of cells with green ﬂuorescent signal was
0%, 9%, 11%, 52%, and 80% for the control HSC-T6 cells
and the cells treated with mYGJ at the concentration of
100μg/mL, 300μg/mL, 600μg/mL, and 1200μg/mL, respec-
tively, (Figure 1(c)). These data indicate that mYGJ induces
HSC-T6 cell apoptosis in a dose-dependent manner.
3.2. mYGJ Enhances ROS Accumulation and Facilitates Cal-
cium and Cytochrome c Release. One component of mYGJ,
Melia toosendan Sieb, was reported to induce primary hepa-
tocyte death process by generation of ROS and MAP kinases
activation[14].TodelineateROSgenerationaccountsforthe
underlying mechanisms of mYGJ-mediated HSCs apoptosis,
the HSC-T6 cells were treated with various concentrations
of mYGJ and the levels of ROS generation were measured.
As shown in left panel of Figure 2(a),R O Sg e n e r a t i o n
was increased in a dose-dependent manner. The mYGJ-
(600μg/mL) induced ROS accumulation can be partially
reversed when HSC-T6 cells were pretreated with catalase
(600U/mL) for 2 hours (Figure 2(a), right panel). These
results suggest that mYGJ enhances ROS accumulation
leading to apoptosis of HSCs.
To reveal whether ROS-mitochondrial signaling is
involved in mYGJ-induced apoptosis, HSC-T6 cells were
treated with various concentrations of mYGJ and the
cytosolic concentration of calcium and cytochrome c was
measured. By staining the cells with Fluo-4/AM followed
by ﬂow-cytometry analysis, our data revealed that mYGJ
caused an increase in the concentration of cytosolic calcium
in a dose-dependent manner of mYGJ (Figure 2(b)). On
the other hand, Western blot analysis of the cytosol and
mitochondria fraction of the mYGJ-treated HSC-T6 cell
lysates revealed an increase in cytosolic cytochrome c and a
decreaseinmitochondrialcytochromec inadose-dependent
manner of mYGJ (Figure 2(c)). These data indicate that
the mYGJ-induced HSCs apoptosis is mediated by the
mitochondria-dependent pathway.
3.3. mYGJ Induces HSC-T6 Cell Apoptosis Through a Caspase-
Dependent Pathway. In the intrinsic pathway, death signals
actdirectlyorindirectlyonthemitochondria,resultinginthe
release of cytochrome c. Members of the B-cell lymphoma
protein-2 (Bcl-2) family play an important role in regulation
of cytochrome c release and cytochrome c-mediated apop-
tosis [15]. To validate mYGJ induced-cytochrome c release
in HSC-T6 cells was controlled by proteins of Bcl-2 family,
the antiapoptotic factor Bcl-2 and proapoptotic factor Bax
expressionwereanalyzedinmYGJ-treatedHSC-T6cells.Our
data indicated that mYGJ resulted in a decrease in Bcl-2 and
a moderate increase in Bax (Figure 3(a)).
Caspase activation is the key event in apoptotic cell
death. To further verify that mYGJ-induced apoptotic death
in HSC-T6 cells, the activation status of caspase 3, 8, and
9 in mYGJ-treated HSC-T6 was measured by Western blot
analysis. The active and cleavage forms of caspase 3 and 9
wereobservedinthelysatesofHSC-T6cellsthatweretreated
with 300, 600, and 1200μg/mL of mYGJ (Figures 3(b) and
3(c)). In contrast, no active form of caspase 8 was observed
in these cell lysates (data not shown).
Alteration of intracellular calcium homeostasis plays an
important role in initiating the apoptotic response. It may
be promoted by ROS accumulation or from endoplasmic
reticulum (ER) stress. Calpain and caspase 12 are the two
major ER-related cell death signaling molecules, while GRP-
78 is a well known marker of ER stress. To determine
whether the calcium release-activated apoptosis of mYGJ-
treatedHST-6cellswasassociatedwithERstress,thecleavage
of caspase 12 was analyzed by Western blot analysis. Our
data revealed that mYGJ treatment increased caspase 12
cleavage concomitant with the increase in the expression
of GRP-78 but not calpain (Figure 3(d)). Together, these
results suggest that mYGJ induces ER stress and caspase 12
activation following caspase 9 and 3 activation leading to cell
death of HSC-T6.
4. Discussion
Traditional Chinese medicine has been used in China for
thousandsofyears.Recipesfortreatmentofliverdiseasesuch
as liver ﬁbrosis have been demonstrated to improve clinical
management of patients. Here, we report the ﬁrst evidence-
based study to elucidate that mYGJ elicits its antiﬁbrotic
activity through inhibition of HSCs activation and down-
regulation of α-SMA and Bcl-2 expression. Furthermore,
mYGJ induces HSCs apoptosis via ROS production and
calcium release leading to intrinsic caspase-3 activation.
This study thereby provides new mechanistic insight for the
pharmaceutical eﬀects of mYGJ in the treatment of patients
with liver ﬁbrosis.
Of the mYGJ components, Astragalus membranaceus has
been shown to elicit antiﬁbrotic eﬀect through inhibition of
collagen synthesis and HSCs proliferation [16]. Moreover,
Carapax trionycis may cause a decrease in the number of
activated HSC and the total number of HSC [17]. These
ﬁndings are in accord with our data and support the view
that the antiﬁbrotic eﬀect of mYGJ is mainly mediated
through regulation of HSCs proliferation and activation. In
contrast, Sho-saiko-to (TJ-9) inhibits the proliferation of
HSCs by induction of cell cycle arrest at the G0/G1 phase
[18] and changes the balance of MMPs/TIMPs [19]. TheseEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: mYGJ enhances ROS accumulation and facilitates calcium and cytochrome c release (a) HSC-T6 cells were treated with the
indicated concentrations of mYGJ for 24 hours and production of ROS was analyzed by percentage of H2DCFDA-stained cells which were
determined by ﬂow cytometry (left). Moreover, the HSC-T6 cells that were treated with 600μg/mL of mYGJ were preincubated with catalase
(600U/mL) 2 hours before ROS measurement by ﬂow cytometry. H2O2 was used as positive control for the experiment (right). The data
represented the mean ± S.E. of three independent experiments. (b) HSC-T6 cells were treated with the indicated concentrations of mYGJ
for 48 hours and calcium release was measured by percentage of Fluo-4/AM-stained cells which were determined by ﬂow cytometry. The
values ∗P<. 05 and ∗∗P<. 01 when compared with control cells were considered statistically signiﬁcant by the paired sample t-test. The
zero concentration was deﬁned as control. (c) HSC-T6 cells were treated with the indicated concentrations of mYGJ. The cell lysates were
harvested at 72 hours post-treatment followed by subfractionation into mitochondria and cytosolic fraction. Western blot analysis was then
performed using the anticytochrome c antibody. The expression of β-actin was used for the control of equal protein loading. The band
intensity of Bcl-2 or Bax versus β-actin was determined and the relative ratio to control experiment which did not treat with mYGJ was
indicated below the data.
studies together imply that diﬀerent recipes of traditional
Chinese medicine play diverse roles in suppression of HSC
activation and may have diﬀerent eﬃcacy in improving the
clinical outcome of patients with liver ﬁbrosis.
At least two distinct cellular pathways leading to HSC
apoptosis account for the antiﬁbrotic activity of mYGJ. At
ﬁrst, excessive ROS generation is crucial to mYGJ-induced
HSC apoptosis (Figure 2(a)). This notion is consistent with
a previous study reporting a component of mYGJ, Melia
toosendan Sieb, induces hepatocyte death by production
of ROS [14]. At low/moderate concentrations, ROS elic-
its beneﬁcial eﬀects on several important physiological
responses, such as oxygen sensing, angiogenesis, control
of vascular tone, regulation of cell growth, diﬀerentiation,6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: The mYGJ induces HSC-T6 cell apoptosis through a caspase-dependent pathway. (a) HSC-T6 cells were treated with the indicated
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and migration, in defense against infectious agents and the
induction of a mitogenic response [20, 21]. In contrast,
excessive ROS production induces cellular damage, such as
cause of DNA damage and oxidation of proteins, impairs
mitochondrial respiration, and is implicated in cell death. In
this study, we reveal that the antiﬁbrotic eﬀect of mYGJ is
closely related to ROS generation leading to HSC apoptosis.
On the other hand, mYGJ may stimulate an increase
of intracellular calcium and activate ER stress and mito-
chondrial pathway leading to the induction of apoptosis.
According to the data we present in this study, mYGJ
may induce ER stress with the Bax in the ER membrane
undergoing conformational alteration and permit calcium
release. Calpain is a calcium-dependent cysteine protease
which is activated by release of calcium and subsequently
activates procaspase 12 or causes mitochondrial membrane
potential loss leading to the release of cytochrome c [19,
22]. However, calpain was not signiﬁcantly changed in
HSCs under mYGJ treatment while activated caspase 12
was detected in this condition (Figure 3(d)). It is likely
that caspase 12 is activated by a calpain-independent
manner. In accord with this notion, caspase 12 has been
shown to be activated by the upstream caspase 7 which
is activated by caspase 9 [22]. Alternatively, Bax directly
causes mitochondria to release cytochrome c and activate
caspase 9 [23]. Besides, Mattson and Chan have shown
that small amounts of cytochrome c released from mito-
chondria function in a positive feedback loop by bind-
ing to Inositol phosphate-3 receptor on the endoplasmic
reticulum, triggering calcium release, and thus amplify-
ing calcium-dependent apoptosis [24]. These molecular
changes together induce HSC apoptosis and account forEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Hypothetical pathways by which mYGJ induces apoptosis
of HSC-T6 cells. mYGJ promotes proapoptotic factor Bax expres-
sion, decreases antiapoptotic factor Bcl-2 expression, and along
with the accumulation of ROS facilitates calcium and cytochrome
c release to cytosol followed by activation of caspase 9 and caspase
3 leading to apoptosis. On the other hand, mYGJ may induce ER
stress that results in an increase in cytosolic calcium concentration
and activates-ER-associated caspase 12 subsequently joints the
activation of caspase 9/ 3 cascade.
the therapeutic eﬀects of mYGJ on HSC activation and liver
ﬁbrosis.
Until now, how mYGJ mediates ROS generation in
HSC is not yet completely understood. In aerobic cells,
the mitochondrial respiratory chain is the major cellular
source for ROS. It originates as a byproduct of oxygen
metabolism in the electron transport chain within the
mitochondria. ROS are also generated by tightly regulated
cellular enzymes such as NADPH oxidase [20]. Hence,
mYGJ may sustain ROS production by modulation of
mitochondrial respiratory chain activity or, alternatively,
regulating NADPH oxidase activity. Although the detailed
molecularmechanismsremaintobeinvestigatedfurther,our
data reported in this study indicate that mYGJ regulates Bcl-
2-asscociated mitochondria signaling and thereby supports
the notion that mYGJ modulates mitochondrial respiratory
chain and causes excessive ROS production leading to cell
apoptosis.
T o g e t h e r ,o u rd a t as u p p o r tam o d e lo fa c t i o nf o rm Y G J -
mediated suppression of HSC activation as illustrated in
Figure 4. In this notion, mYGJ induces the intrinsic pathway
of apoptosis that involves Bcl-2-regulated mitochondria
signaling, followed by enhancement of ROS accumulation
and an increase in cytochrome c release from mitochondria
to cytosol. On the other hand, mYGJ may induce ER stress
that results in an increase in cytosolic calcium concentration
and activation of caspase 12. Both pathways activate caspase
9/caspase 3 leading to activated HSC apoptosis. Whether
mYGJ also elicits antiﬁbrotic eﬀect in vivo in the liver ﬁbrosis
animal model and is in accord with the mode of action we
propose here is under investigation.
5. Conclusion
The mYGJ is a popular Chinese herbal medicine recipe and
is widely administered to patients with chronic hepatitis and
liver cirrhosis. Our results indicated that mYGJ inhibited the
accumulation of activated HSCs and reduced HSC-activated
marker α-SMA expression through an ROS-mediated intrin-
sic apoptosis pathway. Furthermore, ER stress-associated
signalling may also be involved in the mYGJ-induced HSC
apoptosis. We demonstrate for the ﬁrst time the molecular
basis for the antiliver ﬁbrosis eﬀect of mYGJ. This study
may lead to new insight regarding how diﬀerent traditional
Chinese medicine recipes may be combined, according to
their mechanisms of action, for treatment of liver ﬁbrosis to
elicit the maximal beneﬁcial eﬀects to the patients.
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